The United Laboratories International Holdings (ULIHF) Financial Statements
The United Laboratories International Holdings Financial Overview
The United Laboratories International Holdings's market cap is currently $1.72B. The company's EPS TTM is $0.28; its P/E ratio is 20.80; and it has a dividend yield of 4.37%. The United Laboratories International Holdings is scheduled to report earnings on March 30, 2027, and the estimated EPS forecast is $0.03. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 13.21B | $ 13.76B | $ 13.74B | $ 11.33B | $ 9.70B |
| Gross Profit | $ 5.51B | $ 6.08B | $ 6.33B | $ 4.97B | $ 4.21B |
| Operating Income | $ 2.27B | $ 3.12B | $ 3.29B | $ 2.02B | $ 1.41B |
| EBITDA | $ 2.87B | $ 3.43B | $ 3.98B | $ 2.57B | $ 2.00B |
| Net Income | $ 2.09B | $ 2.66B | $ 2.70B | $ 1.58B | $ 988.10M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 11.24B | $ 6.33B | $ 4.26B | $ 4.74B | $ 3.33B |
| Total Assets | $ 30.91B | $ 25.83B | $ 21.02B | $ 18.98B | $ 16.33B |
| Total Debt | $ 4.99B | $ 3.16B | $ 1.50B | $ 2.46B | $ 1.84B |
| Net Debt | $ -6.25B | $ -3.17B | $ -2.76B | $ -2.28B | $ -1.49B |
| Total Liabilities | $ 13.34B | $ 11.40B | $ 8.27B | $ 8.37B | $ 6.99B |
| Stockholders' Equity | $ 17.40B | $ 14.39B | $ 12.73B | $ 10.61B | $ 9.34B |
| Cash Flow | |||||
| Free Cash Flow | $ 855.45M | $ 1.33B | $ 977.50M | $ 1.25B | $ 1.06B |
| Operating Cash Flow | $ 3.75B | $ 3.20B | $ 2.44B | $ 2.03B | $ 1.54B |
| Investing Cash Flow | $ -2.17B | $ -1.73B | $ -1.56B | $ -594.92M | $ -587.22M |
| Financing Cash Flow | $ 2.78B | $ 596.91M | $ -1.36B | $ -24.17M | $ -620.93M |
Currency in CNY